apo-atomoxetine
arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg - capsule - 80 mg - active: atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg excipient: gelatin iron oxide red iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide water - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.
apo-atomoxetine atomoxetine (as hydrochloride) 80 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 40 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 18 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 25 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 100 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 10 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine atomoxetine (as hydrochloride) 60 mg capsule blister pack
apotex pty ltd - atomoxetine hydrochloride -
apo-atomoxetine capsule
apotex inc - atomoxetine (atomoxetine hydrochloride) - capsule - 80mg - atomoxetine (atomoxetine hydrochloride) 80mg - miscellaneous central nervous system agents
apo-atomoxetine atomoxetine (as hydrochloride) 80 mg capsule blister
arrotex pharmaceuticals pty ltd - atomoxetine hydrochloride, quantity: 91.2 mg (equivalent: atomoxetine, qty 80 mg) - capsule, hard - excipient ingredients: gelatin; iron oxide yellow; iron oxide red; pregelatinised maize starch; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.